418 studies found for:    multiple myeloma | thalidomide
Show Display Options
Rank Status Study
1 Active, not recruiting Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
Conditions: Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: carfilzomib;   Drug: cyclophosphamide;   Drug: thalidomide;   Drug: dexamethasone
2 Active, not recruiting Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: clarithromycin;   Drug: thalidomide;   Drug: dexamethasone
3 Completed Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide plus dexamethasone;   Drug: Dexamethasone
4 Completed
Has Results
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Ara-C;   Drug: BCNU;   Drug: Cisplatin;   Drug: Cytoxan;   Drug: Dexamethasone;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Filgrastim;   Drug: Recombinant GM-CSF;   Drug: Interferon-alpha-2b;   Drug: Melphalan;   Drug: Vincristine
5 Completed A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: A (Thalidomide + Dexamethasone);   Drug: B (Placebo + Dexamethasone)
6 Active, not recruiting
Has Results
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: melphalan;   Drug: prednisone;   Drug: thalidomide;   Drug: lenalidomide
7 Completed Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.
Condition: Multiple Myeloma de Novo Treatment
Interventions: Drug: Thalidomide, Dexamethasone;   Drug: Vincristin , Adriamycin, Dexamethasone = VAD;   Drug: Thalidomide, melphalan, endoxan, dexamethasone (MCDex-Thal);   Drug: melphalan, endoxan, dexamethasone (MCDex)
8 Terminated S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: etoposide;   Drug: thalidomide
9 Unknown  Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide, Cyclophosphamide, Dexamethasone;   Drug: Thalidomide, Dexamethasone;   Drug: Thalidomide, Melphalan, Prednisone
10 Completed Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Dietary Supplement: ascorbic acid;   Drug: arsenic trioxide;   Drug: bortezomib;   Drug: dexamethasone;   Drug: thalidomide;   Drug: Aspirin
11 Completed Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
12 Completed Thalidomide-Dexamethasone for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Dexamethasone
13 Completed Thalidomide to Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: thalidomide;   Drug: placebo
14 Completed
Has Results
A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Dexamethasone;   Drug: DOXIL
15 Completed Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide Celgene™
16 Active, not recruiting Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide and low-dose dexamethasone;   Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles;   Drug: Melphalan, Prednisone and Thalidomide
17 Completed Thalidomide for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
18 Terminated Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
Condition: Newly Diagnosed, Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: melphalan, prednisone;   Drug: melphalan, prednisone, thalidomide
19 Active, not recruiting
Has Results
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
Conditions: DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma
Interventions: Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide;   Drug: Thalidomide
20 Terminated
Has Results
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: bortezomib;   Drug: dexamethasone;   Drug: thalidomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years